ZempiloUkulungiselela

Iyeza 'Rinofluimucil': ukuphononongwa

Isilwanyana "Rinofluimucil" sisetyenziswe kwi-ENT-practice kwaye sinesiphumo se-vasoconstrictive and mucolytic. Isekelwe kuma-antioxidants kunye ne-antibacterial components, ezinceda ukukhululeka ekungxineni kwamanzi. I-Acetylcysteine, equlethwe kwisizabisi, iyanciphisa ukukhutshwa kwe- mucus. Iyeza "Rinofluimucil" ukuhlaziywa ziphikisana kakhulu. Omnye unceda ngokukhawuleza (nangona sinusitis eqinile, "engazange ilahle" kwezinye iyeza), abanye bathi akazange ancedise nonke. Kumntu othile, isixhobo sele sisisityebi esibalulekileyo, kwaye umntu wadabuka ngemali esetshenzisiweyo. Ngendlela, ixabiso leziyobisi likhulu kakhulu.

Isilwayo "iRinofluimucil" yokuphononongwa kwabantwana sinokufanayo. Iziphumo zokusetyenziswa kwazo ziyamangalisa. Abantu abasebenzisa iilisi, bacebise ukuba basebenzise njengedonsa, kungekhona i-spray. Kucingelwa ukuba kule fomu iyasebenza kakhulu. Kukho izilwanyana "I-Rinofluimucil" ihlaziywa kumaziko amaninzi, ngoko ukuba ufuna ukuba ungawafunda. Unokufunda kwakhona ngazo zonke iziphumo ezichaphazelekayo ezinokufumaneka kule nqaku. Zonke iingqinisiso ziqulethe kwiyeza "Rinofluimucil". Amayeza aneengxelo ezintle ukuba iimfuno zokusetyenziswa kwazo zigcinwa. Isikhokelo sichaza ngokupheleleyo yonke imiphumo engathandekiyo yokuba abantu abasebenzisa amayeza bangalindela.

Phakathi kweempembelelo ezinokuthi zibe yi-tachycardia, inyikima nokunyuka kwengcinezelo yegazi. Oku kubangelwa kwenye yezinto eziphambili ze-drug-thiamine-heptane. Unoxanduva lokubonakala kwentswelo yokuxhalabisa. Ukongezelela, iilisi liyalutha. Ngenxa yokulawulwa kwexesha elide, ukusetyenziswa kakuhle kweembrane zomlomo zempumlo kunokwenzeka. Ngokungenelanga okungafanelekanga, umlomo owomileyo, i-pharynx kunye neempumlo zingabonakala. Ngokwengxenye kwiyeza "Rinofluimucil" ukuhlaziywa okungahambiyo kudibene nezo zinto. Kwaye inxalenye - kunye nokungasebenzi kwayo. Ukuze uphephe imiphumo emibi, kufuneka usebenzise le nkunkuma kungekho iintsuku ezingama-7. Kubantu abadala, isilinganisi esisodwa sinokunyanzeliswa ezimbini kwi-valve, kubantwana - inkunzi eyodwa. Ngosuku ongasebenzisa ngayo amaxesha angama-3-4, akukho. Emva kweveki yonyango, kufuneka uyeke ukusebenzisa iyeza, kungakhathaliseki ukuba uncedise okanye awuncede. Ukusebenza kwechiza kuxhomekeke kwiimpawu zomntu ngamnye. Imiphumo emibi ingaba ngabanye, ngokukodwa, kwabanye abantu kukho ukunganyanzeliseki kumalungu ngamnye kwilisi "Rinofluimucil" (ukuchazwa nokuhlaziywa okunjalo).

Isilwanyana saziwa kwaye sapapashwa ngokubanzi. Nangona kunjalo, ukuze uhlolisise ngokupheleleyo, kufuneka uzame ukusebenzisa isicelo. Ukusetyenziswa kwezidakamizwa "Rinofluimucil" zilungile ukuba zonke iinkqubo zokuthotyelwa kwemilinganiselo zisetyenziswa. Isilwanyana asivumelekanga ukusebenzisa i-thyrotoxicosis kunye ne- zakratougolnoy glaucoma, kunye nokuba kukho ukunganyanzelwanga kwezinto ezithile zeziyobisi. Ngexesha lokukhulelwa kunye nokuncelisa, sebenzisa iyeza "Rinofluimucil" ngokulumkisa. Ukuba kukho enye inkunkuma kwisiza, kungcono ukuba ungayisebenzisi. Abantwana ukuya kwiminyaka emibini yesilwanyana ayinconywanga, nangona kunjalo, njengento yokugqibela yokusetyenziswa, ingasetyenziswa. Abantwana kufuneka banikezwe ngononophelo ngokugqithiseleyo ukuze bagweme imiphumo emibi (emva kokubonisana nodokotela wezingane okanye i-lor).

Nge-asthma ye-bronchial, kunye ne-stenocardia kunye nomfutho wegazi ophezulu, kungcono ukuba ungasebenzisi iyeza. Oku kubangelwa ukubunjwa kweziyobisi, ezinokuphucula iimpawu zezi zifo. Ukuba kukho imfuneko yokusetyenziswa kweyeza, kungcono ukutyelela ugqirha wokuya ngaphambi kokuthatha iyeza. Isalathiso esiyinhloko sokusetyenziswa kweziyobisi iindidi ezahlukeneyo ze-rhinitis ne-sinusitis. Xa kuthathwa ingxaki yomzimba, kungcono ukuyeka ukuthatha amayeza kwaye udibane nodokotela. Ukubonisana ne-therapist kucebise ukuba uhambe phambi kwesicelo ukukhusela zonke iintlobo zemiphumo emibi.

Similar articles

 

 

 

 

Trending Now

 

 

 

 

Newest

Copyright © 2018 xh.atomiyme.com. Theme powered by WordPress.